Recombinant factor VIIa for uncontrollable bleeding in patients with extracorporeal membrane oxygenation: report on 15 cases and literature review

INTRODUCTION: Bleeding is the most frequent complication in patients receiving venoarterial or venovenous extracorporeal membrane oxygenation (ECMO). Recombinant activated factor VII (rFVIIa) has been used in these patients with conflicting results. We describe our experience with rFVIIa for refract...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: Repessé, Xavier, Au, Siu Ming, Bréchot, Nicolas, Trouillet, Jean-Louis, Leprince, Pascal, Chastre, Jean, Combes, Alain, Luyt, Charles-Edouard
Format: Artigo
Jezik:Inglês
Izdano: BioMed Central 2013
Teme:
Research
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC4057417/
https://ncbi.nlm.nih.gov/pubmed/23531278
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/cc12581
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki